Reclaimed at end of life
Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.
py_column_contradicts_prior_filing. AmountOfRecycled for period ending 2024-03-31 reported as [0.0, 252.0] in different filings. Restated or mis-tagged.
| Category | FY 2023-24 |
|---|---|
| Plastics including packaging | not filed |
| E-waste | not filed |
| Hazardous waste | not filed |
| Other waste | 1,466 |
| Total reclaimed | 1,466 |
Recycled or reused input material
Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.
| Input material, as filed | FY 2023-24 |
|---|---|
| Since we are in the pharmaceutical business, we do not recycle or reuse input material. | 0.0% |
NIC codes filed
Products and services accounting for 90 percent of turnover, latest filing.
| Code | Description as filed | Share of turnover |
|---|---|---|
| 24231 | Manufacture of chemical substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure sugar etc. | 2.18% |
| 51397 | Wholesale of pharmaceutical and medical goods | 38.53% |
| 24232 | Manufacture of allopathic pharmaceutical preparations | 59.29% |
Source filings
| Year | Basis | Taxonomy | Turnover as filed |
|---|---|---|---|
| FY 2023-24 | Consolidated basis | 2024-04-30 | 1,80,57,40,19,225.61 |
Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error